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SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: May 17, 2001
SUBJECT: Research News (#2)
                                                                                                                                                                        
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Alice Clark (P.I. – RIPS/NCNPR) and Dr. Larry Walker (Co-P.I. - RIPS/NCNPR) –
Development of Natural Products from Plants and Microbes for Replacement of Synthetic Pesticides
(Amendment 7) (USDA), $1,673,161 – 2001.
2. Dr. Mahmoud ElSohly (P.I. – RIPS/NCNPR) and Dr. Samir Ross (Co-P.I. – RIPS/NCNPR) –
Production, Analysis and Distribution of Cannabis and Marijuana Cigarettes (Amendment 3)
(NIDA), $809,361 – 12/1/00-11/30/01.
3. Dr. Mahmoud ElSohly (P.I. – RIPS/NCNPR) and Dr. Samir Ross (Co-P.I. – RIPS/NCNPR) –
Production, Analysis and Distribution of Cannabis and Marijuana Cigarettes (Modification 4)
(NIDA), $162,212 – 12/1/00-11/30/01.
4. Dr. Mahmoud ElSohly (P.I. – RIPS/NCNPR), Dr. Larry Walker (Co-P.I. – RIPS/NCNPR) and
Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) – Appropriate Quality Control Procedures of Herbal
Drugs in Egypt (USAID Funds via Foreign Relations Coordination Unit, Egypt), $40,000.
5. Dr. Christy Foran (P.I. - RIPS/ECHR) – Use of a Transgenerational Model to Evaluate Threshold
Effects of Endocrine Disrupting Chemicals (U.S. Environmental Protection Agency), $127,773.
6. Dr. Mark Hamann (P.I. - Pharmacognosy) – A Sponge Taxonomy Workshop and Novel
Approaches to the Classification of Species in the Phylum Porifera (Mississippi/Alabama Sea Grant
College Program), $2500.
7. Dr. Charles Hufford (P.I. – RIPS/NCNPR) – NMR Spectral Data for King Saud University (King
Saud University), $10,000.
8. Dr. Eugene Kolassa (P.I. – Pharmacy Administration) – Studies in Pharmaceutical Public Policy
(Astra-Zeneca Pharmaceuticals, Inc.), $40,000 – 2/01-12/01.
 
9. Dr. Dale Nagle (P.I. – Pharmacognosy)  - Control of Blue-green Algae in Aquaculture Ponds (Year
3) (Mississippi State University/Southern Regional Aquaculture Center), $20,000.
10. Dr. Dale Nagle (P.I. – Pharmacognosy)  - Discovery of New Drugs that Target Hypoxic Breast
Tumor Cells (U.S. Army Medical Research Acquisition Activity Award), $72,000.
11. Dr. John Rimoldi (P.I. – Medicinal Chemistry) – Computer Software Predictor of Physiochemical
Parameters: An Alternative to Laboratory Experiments (UM Educational Technology Grant
Program), $2350.
12. Dr. David Rogers (P.I. – Pharmacy Practice) – Molecular Mechanisms of Echinocandin Antifungal
Resistance in a Saccharomyces Cerevisiae Model (Merck & Co., Inc.), $23, 250 – 10/00-10/01.
13. Dr. Samir Ross (P.I. – RIPS/NCNPR) – Development of an Economic Supply of Delta 9 THC
(NIH subcontract with ElSohly Laboratories, Inc.), $201,243.
14. Dr. Marc Slattery (P.I. – Pharmacognosy) – Hybridization of Soft Corals – Combinational Genetics
& Drug Discovery (Mississippi/Alabama Sea Grant College Program), $15,233 – 12/00-12/01.
15. Dr. Mickey Smith (P.I. – Pharmacy Administration) – Diversity Recruitment Initiative (Pfizer,
Inc.), $9,224 – 2/01-12/01.
16. Dr. Larry Walker (P.I. – NCNPR) and Dr. Alice  Clark (Co-P.I. – NCNPR) – Natural Products
Acting via New Anti-Fungal Targets (Modification 1) (Georgetown University/National Cancer
Institute), $168,744.
17. Dr. Kristine Willett (P.I. – Pharmacology) – Screening of Environmental Contaminates Detected in
Mississippi Sediments as Inducers and/or Inhibitors of CYP1B1 Expression in Channel Catfish
(Mississippi State University/U.S. Dept. of the Interior, U.S. Geological Survey), $20,047 – 3/01-
2/02.
18. Dr. John Williamson (P.I. – Medicinal Chemistry) – UM’s Biomedical Research Internship
Program (National Institute of General Medical Sciences), $175,636 – 2/01-1/02.
19. Dr. John Williamson (P.I. – Medicinal Chemistry) – Multimedia Tool Box for Science-Related
Courses (UM Educational Technology Grant Program), $5500.
20. Dr. Yu-Dong Zhou (P.I. – RIPS/NCNPR) – Natural Products as Modulators of Therapeutic
Angiogenesis in Ischemic Diseases (American Society of Pharmacognosy Research Starter Grant),
$7500.
21. Dr. Jordan Zjawiony (P.I. – Pharmacognosy) and Dr. Mark Hamann (Co-P.I. – Pharmacognosy) –
Design and Synthesis of New Anticancer and Antitubercular Agents Based on Marine Natural
Product, puupehenone (Mississippi/Alabama Sea Grant Consortium), $49,968 – 2/01-1/04.
The following PUBLICATIONS have appeared:
1. E. Bedir and I.A. Khan – “A New Cyclolanostanol Arabinoside from the Rhizome of Cimicifuga
racemosa”, Pharmazie, 56, pp. 268-269, 2001.
2. R. Bekker, X.C. Li, H.N. ElSohly, A.M. Clark, E.V. Brandt and D. Ferreira – “Resolution and
Absolute Configuration of Naturally Occurring Auronols”, Journal of Natural Products, 64, pp. 345-
347, 2001.
3. L. Bennie, J. Coetzee, E. Malan, J.R. Woolfrey and D. Ferreira – “Oligomeric flavanoids. Part 34:
Doubly-linked proteracacinidin analogues from Acacia caffra and Acacia galpinii”, Tetrahedron, 57,
pp. 661-667, 2001.
4. A. Brown, M. Andrew, T. Clemons, D. King , H. Taylor, M. Wofford, W. Wyatt and D. Jones –
“Classification of JNC VI Blood Pressure Stages and Risk Groups in the ARIC Study”, Am J
Hypertension, 13, 2000.
5. W.M. Davis – “Dietary Supplements: Are They Safe and Reliable?”, Drug Topics, pp. 61-72, April
16, 2001.
6. H.N. ElSohly, A.S. Joshi, A.C. Nimrod, L.A. Walker and A.M. Clark – “Antifungal Chalcones
from Maclura tinctoria”, Planta Med, 67, pp. 87-89, 2001.
7. M. Ganzera, E. Bedir, I. Calis and I.A. Khan – “Separation of Astragalus Saponins by Reversed
Phase High Performance Liquid Chromatography and Evaporative Light Scattering Detection”,
Chromatographia, 53, pp. 131-134, 2001.
8. K.G. Harkins, D.S. King, M.R. Wofford, C.A. Brown, S.B. Wyatt, M.E. Miller-Davis, L.A. Ramsey
and D.W. Jones – “Screening for Dyslipidemia in Resident Training Clinics: Is Cardiovascular Risk
Management Adequate?”, Am J Hypertension, 13, 2000.
9. T.K. Harrell and D.S. King – “Morton Selected for Community Health Project”, Spirit of Morton, 4,
p. 1, 2001.
10. T.K. Harrell, N.N. Horton, D.S. King, M.R. Wofford, A.K. Low and S.L. Noble – “Women’s
Health Initiative of Mississippi: An Innovative Approach to Promoting Wellness”, Obesity Research, 8,
p. 104S, 2000.
11. T.K. Harrell, W.W. Newcomb, W.H. Replogle, D.S. King and S.L. Noble – “Onychomycosis:
Improved Cure Rates with Itraconazole and Terbinafine”, Journal of the American Board of Family
Practice, 13, pp. 268-273, 2000.
12. D.B. Huggett, J.A. Steevens, J.C. Allgood, C.B. Lutkin,  C.A. Grace, and W.H. Benson –
“Mercury in  Sediment and Fish from North Mississippi Lakes”, Chemosphere, 42, pp. 923-929,
2001.
13. M. Ilias, D.C. Dunbar, S. Takamatsu, L.A. Walker and A.M. Clark – “Antimalarial, Cytotoxic
and Antifungal Alkaloids form Duguetia hadrantha”, Journal of Natural Products, 2001.
14. M. Ilias, K.A. ElSayed, J.S. Mossa, M.S. AlSaid, F.S. El-Feraly, A.M. Clark, C.D. Hufford, S. Oh
and A.M.S. Mayer – “Bioactive 12-Oleanene Triterpene and Secotriterpene Acids from Maytenus
undata”, J. Nat. Prod., 63, pp. 605-610, 2000.
15. M. Ilias, I.A. Khan, N.H. Fischer and F.R. Fronczek – “Two Stereoisomeric Pentacyclic Oxindole
Alkaloids from Uncaria Tomentosa: Uncarine C and Uncarine E”, Acta Cryst, 57, pp. 480-482, 2001.
16. I. Katsuyama, A.A. Khalil, J. Ren and J.K. Zjawiony – “New and Unique Heterocyclic System with
a Fused Imidazole Ring”, Heterocycles, 54, pp. 721-726, 2001.
17. D.S. King, D.W. Jones, M.R. Wofford, K.G. Harkins, T.K. Harrell and K.W. Kelley – “Cognitive
Impairment Associated with Atorvastatin”, Pharmacotherapy, 21, p. 36, 2001.
18. D.S. King, S.L. Noble, T.K. Harrell and M.R. Wofford – “Education, Service and Pharmaceutical
Care Opportunities for Pharmacy Students Through Medical Missions”, Pharmacotherapy, 21, p. 107,
2001.
19. D.S. King, S.L. Noble, K.G. Harkins, M.R. Wofford, K. Harrell, L.A. Ramsey, W.H. Replogle and
B.H. Tidwell – “Evaluation of Compliance with National Cholesterol Education Program
Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care
Clinics”, Pharmacotherapy, 20, p. 1235, 2000.
20. D.S. King, S.B. Wyatt, M.R. Wofford, K. Harrell and D.W. Jones – “Improvement in Blood
Pressure Control Through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients
with Multiple Metabolic Syndrome”, Pharmacotherapy, 20, p. 1235, 2000.
21. D.S. King and M.R. Wofford – “Identification/Management of Obstructive Sleep Apnea”, Drug
Topics, 144, pp. 41-50, 2000.
22. D.S. King, S.B. Wyatt, N.S. King, M.R. Wofford, L.H. Statham, M.M. Pearson, T.K. Harrell and
D.W. Jones – “Improvement in Blood Pressure Control Through Interdisciplinary Medication
Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome”, Am J Hypertension,
13, 2000.
23. D.S. King and M.R. Wofford – “Obesity and New-Onset Diabetes Mellitus”, Drug Topics, 144, pp.
69-78, 2000.
24. D.S. King and M.R. Wofford – “Obesity and Hypertension”, Drug Topics, 144, pp. 59-68, 2000.
25. M. Murawski and J.P. Bentley – “Pharmaceutical Therapy-Related Quality of Life: Conceptual
Development”, Journal of Social and Administrative Pharmacy, 8, pp. 2-14, 2001.
26. S.L. Noble, D.S. King, D. Price, D.M. Phillips, T.K. Harrell and W.H. Replogle – “Assessing and
Advising Women for Breast Cancer Risks and Treatment Option”, Pharmacotherapy, 21, p. 136,
2001.
27. S.L. Noble, D.S. King and J.L. Olutade – “Cyclooxygenase-2 Enzyme Inhibitors: Place in
Therapy”, Am Family Physician, 61, pp. 3669-3676, 2000.
28. K.Y. Orabi, J.S. Mossa, M. Ilias, M.H. Alloush, A.M. Galal, F.S. El-Feraly and A.T. McPhail –
“New Eudesmane Sesquiterpens from Plectranthus cylindraceus”, Journal of Natural Products, 63,
pp. 1665-1668, 2000.
29. C.C. Pace and K.C. Rogers – “Bustin’ Open: A Single-session Case of Hypertensive Crisis”, The
Journal of Clinical Problem-based Learning, 4, pp. 4-10, 2000.
30. N. Pugh, S.A. Ross, M.A. ElSohly  and D.S. Pasco – “Characterization of Aloeride, a New High-
Molecular-Weight Polysaccharide for Aloe vera with Potent Immunostimulatory Activity”, Journal
of Agricultural and Food Chemistry, 49, pp. 1030-1034, 2001.
31. N. Pugh, I.A. Khan, R.M. Moraes and D.S. Pasco – “Podophyllotoxin Lignans Enhance IL-1β But
Suppress TNF-α mRNA Expression in LPS-Treated Monocytes”, Immunopharmacology and
Immunotoxicology, 23, pp. 83-95, 2001.
32. M.A. Repka and J.W. McGinity – “Bioadhesive Properties of Hydroxypropylcellulose Topical
Films Produced by Hot-Melt Extrusion”, Journal of Controlled Release, 70, pp. 341-351, 2001.
33. K.C. Rogers and D.A. Wolfe – “Ibutilide: A Class III Rapidly Acting Antidysrhythmic for Atrial
Fibrillation or Atrial Flutter”, The Journal of Emergency Medicine, 20, pp. 67-71, 2001.
34. K.C. Rogers and P.D. Rogers – “Recent Treatment Strategies for Acute Coronary Syndromes”,
Hospital Pharmacist Report, 14, pp. 29-38, 2000.
35. K.C. Rogers and D.A. Wolfe – “Amiodarone-induced blue-gray Syndrome”, The Annals of
Pharmacotherapy, 34, p. 1075, 2000.
36. M.Y. Salem, S.A. Ross, T.P. Murphy and M.A. ElSohly  – “GC-MS Determination of Heroin
Metabolite in Meconium: Evaluation of Four Solid-Phase Extraction Cartridges”, Journal of
Analytical Toxicology, 25, pp. 93-98, 2001.
37. S.R. Snodgrass and B. Parks – “Anticonvulsant Blood Levels: Historical Review with a Pediatric
Focus”, Journal of Child Neurology, 15, pp. 734-746, 2000.
38. E.M. Ulrich, K.L. Willett, A. Caperell-Grant, R.M. Bigsby and R.A. Hites – “Understanding
Enantioselective Processes: A Laboratory Rat Model for α-Hexachlorocyclohexane Accumulation”,
Environ. Sci. Technol., 35, pp. 1604-1609, 2001.
39. K.L. Willett, L.A. Lienesch and R.T. DiGiulio – “No Detectable DNA Excision Repair in UV-
exposed Hepatocytes from Two Catfish Species”, Comparative Biochemistry and Physiology Part C,
128, pp. 349-358, 2001.
40. J.S. Williamson and C.M. Wyandt – “New Perspectives on Alternative Medicines”, Drug Topics,
pp. 57-65, January 2001.
41. M.R. Wofford, D.S. King, S.B. Wyatt and D.W. Jones – “Secondary Hypertension: Detection and
Management for the Primary Care Provider”, Journal of Clinical Hypertension, pp. 124-131, 2000.
42. M.R. Wofford, M.E. Andrew, D.S. King, J. Stevens, S.B. Wyatt, D.W. Jones – “Implications of
Obesity Guidelines to the Atherosclerosis Risk in Communities Cohort”, Ethnicity & Disease, 10, p.
292, 2000.
43. M.R. Wofford, M.W. Davis, K.G. Harkins, D.S. King, J.L. Warnock, S.B. Wyatt and D.W. Jones –
“Screening for Primary Aldosteronism in Hypertensive Patients”, Am J Hypertension, 13, 2000.
The following TECHNOLOGY TRANSFER transactions have occurred:
In the interest of protecting confidential information, the titles of invention disclosures and patent
applications will not be published until after a patent has issued.  Inventors outside of the School of
Pharmacy will not be published until after a patent has issued.
INVENTION DISCLOSURES FILED IN 2001
• Michael Repka, Mahmoud ElSohly et. al.
PATENT APPLICATIONS PENDING
• Ghandehari et. al.
• David Pasco, Nirmal Pugh, Mahmoud ElSohly, Samir Ross
• David  Pasco, Nirmal Pugh, Mahmoud ElSohly, Samir Ross
• Mark  Hamann, Khalid ElSayed, et. al.
• Mitchell A. Avery
• Mitchell A. Avery et. al.
• Mahmoud ElSohly, Samir Ross, et. al.
• N. P. Dhammika Nanayakkara et. al.
RECENT PATENTS GRANTED:
“Method of Screening Agents as Candidates for Drugs or Sources of Drugs”
David Pasco et. al..
USSN: 09/355,940
Issued: March 13, 2001
The following SPECIAL ANNOUNCEMENTS are also listed:
• Jean Baker has been elected to the University’s Staff Council as a representative for a three year
term, ending in February 2004.
• Dr. Walt Chambliss was selected by the Office of the Inspector General of the American
Pharmaceutical Association to participate in a focus group during the APhA Meeting in San
Francisco in March.  The Office of the Inspector General is conducting a study, in cooperation with
the FDA, on the extent to which product labeling serves as a safeguard for the elderly taking dietary
supplements.
• Dr. Steve Duke was named Outstanding Senior Research Scientist of 2000 by the Agricultural
Research Service, chief scientific research agency of the U.S. Dept. of Agriculture.
• Dr. Melissa Flagg, Post Doctoral Research Associate, has been selected as an American Association
for the Advancement of Science Fellow in the Office of the Science and Technology Advisor to the
Secretary of State in the U.S. State Department, effective September 2001.
• Dr. Mark Hamann has been selected to receive the Outstanding Researcher Award in the School of
Pharmacy for 2001.
• Dr. Ikhlas Khan has been selected as guest co-editor from the USA for a special issue of J.
Chromatography B.  He was also chosen as a participant in the two WHO Meetings to be held in
Canada in July, 2001.
• Deborah Lincoln, Undergraduate Student, has been awarded an American Society of Pharmacognosy
Undergraduate Research Grant in the amount of $2500 to pursue her studies on molecular modeling.
• Vernon Rayford, Undergraduate Student, has been awarded a Goldwater Scholarship.
• The 2001 Graduate Student Achievement Awards were presented to Nirmal D. C. Pugh
(Pharmacognosy) and Saurabh S. Sewak (Pharmacy Administration).
Please continue to send me important research and graduate information so that I might share it with
your faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL
OF PHARMACY WEB PAGE!  Thank you.
cc: Interim Dean Robert D. Sindelar
Dean Designate Barbara G. Wells
Ms. Barbara Lago
Ms. Beverly Urbanek
Ms. Dabney Weems
